Dyadic International, Inc. (NASDAQ:DYAI) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
Stay updated with breaking news from Clinical Study Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for DONESTA® to...
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for...
SEATTLE, Nov. 14, 2023 -- Perspective Therapeutics, Inc. , today announced third quarter financial results for the period ended September 30, 2023 and provided recent business highlights.. ...
26.09.2023 - Imperial and US medical technology company MediBeacon have partnered to advance a non-invasive method of assessing intestinal health.